TCIM
VIVO

TIAA CREF Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

TIAA CREF Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.64M Buy
93,309
+3,020
+3% +$50.2K ﹤0.01% 2097
2018
Q4 		$1.57M Sell
90,289
-2,234
-2% -$38.1K ﹤0.01% 2094
2018
Q3 		$1.38M Sell
92,523
-18,678
-17% -$290K ﹤0.01% 2300
2018
Q2 		$1.77M Buy
111,201
+12,807
+13% +$191K ﹤0.01% 2232
2018
Q1 		$1.4M Sell
98,394
-8,031
-8% -$119K ﹤0.01% 2278
2017
Q4 		$1.49M Sell
106,425
-3,540
-3% -$51.8K ﹤0.01% 2283
2017
Q3 		$1.57M Sell
109,965
-5,243
-5% -$74.9K ﹤0.01% 2300
2017
Q2 		$1.81M Buy
115,208
+1,294
+1% +$18.6K ﹤0.01% 2234
2017
Q1 		$1.57M Sell
113,914
-7,013
-6% -$98.1K ﹤0.01% 2278
2016
Q4 		$2.14M Sell
120,927
-8,338
-6% -$146K ﹤0.01% 2154
2016
Q3 		$2.49K Sell
129,265
-2,300
-2% -$45K ﹤0.01% 2055
2016
Q2 		$2.57M Sell
131,565
-4,194
-3% -$82.2K ﹤0.01% 1971
2016
Q1 		$2.8M Sell
135,759
-3,394
-2% -$66.9K ﹤0.01% 1897
2015
Q4 		$2.85M Sell
139,153
-3,189
-2% -$61.1K ﹤0.01% 1939
2015
Q3 		$2.43M Sell
142,342
-2,617
-2% -$47.8K ﹤0.01% 2028
2015
Q2 		$2.7M Buy
144,959
+254
+0.2% +$4.71K ﹤0.01% 2107
2015
Q1 		$2.76M Sell
144,705
-8,599
-6% -$159K ﹤0.01% 2023
2014
Q4 		$2.52M Sell
153,304
-8,330
-5% -$143K ﹤0.01% 2094
2014
Q3 		$2.86M Hold
161,634
– – ﹤0.01% 1989
2014
Q2 		$3.34M Sell
161,634
-753
-0.5% -$15.5K ﹤0.01% 1965
2014
Q1 		$3.54M Sell
162,387
-1,570
-1% -$36K ﹤0.01% 1872
2013
Q4 		$4.35M Sell
163,957
-6,652
-4% -$163K ﹤0.01% 1734
2013
Q3 		$4.04M Sell
170,609
-3,749
-2% -$87.5K ﹤0.01% 1740
2013
Q2 		$3.75M Buy
+174,358
New +$3.76M ﹤0.01% 1739

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

TIAA CREF Investment Management's VIVO Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Meridian Bioscience Inc (VIVO) stake by 3.3% in Q1 2019, buying an estimated $50.2K and bringing the position to 93,309 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #2097.

TIAA CREF Investment Management first reported a position in VIVO in Q2 2013 and has held it in 24 quarters since. The position peaked at $4.35M in Q4 2013. 183 funds tracked by Wall St. Rank hold VIVO as of Q1 2019.

  • TIAA CREF Investment Management held 93,309 shares of Meridian Bioscience Inc worth $1.64M as of Q1 2019.
  • TIAA CREF Investment Management bought 3,020 Meridian Bioscience Inc shares in Q1 2019, an estimated $50.2K.
  • Meridian Bioscience Inc made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2097 holding.
  • TIAA CREF Investment Management first reported a position in Meridian Bioscience Inc in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Meridian Bioscience Inc position peaked at $4.35M in Q4 2013.
  • 183 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.